Notizie Salarius Pharmaceuticals - SLRX

Ultime notizie

Data	Ora	Fonte	Titolo
14/6/2024	22:04	EDGAR2	Form 8-K - Current report
12/6/2024	14:00	GLOBE	Salarius Pharmaceuticals Announces 1-for-8 Reverse Stock..
13/5/2024	22:17	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
22/3/2024	21:05	GLOBE	Salarius Pharmaceuticals Reports Fourth Quarter and Full..
06/3/2024	22:02	EDGAR2	Form 8-K - Current report
22/2/2024	22:29	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
22/2/2024	22:25	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
22/2/2024	22:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
22/2/2024	14:00	GLOBE	Salarius Provides Update on Strategic Review Process and..
16/1/2024	14:00	GLOBE	Salarius Pharmaceuticals Issued U.S. Patent for..
03/1/2024	14:30	GLOBE	Investigator-initiated Phase 1/2 Clinical Trial Using..
09/11/2023	23:04	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/2023	14:30	GLOBE	Salarius Completes FDA Type B Meeting for Seclidemstat Ewing..
27/10/2023	21:57	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
06/9/2023	23:09	EDGAR2	Form 8-K - Current report
10/8/2023	22:14	EDGAR2	Form 8-K - Current report
10/8/2023	22:13	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/2023	22:05	GLOBE	Salarius Pharmaceuticals Reports Second Quarter 2023..
08/8/2023	22:05	GLOBE	Salarius Pharmaceuticals Announces Plans to Explore..
12/7/2023	15:22	EDGAR2	Form 8-K - Current report
11/7/2023	14:30	GLOBE	Salarius Pharmaceuticals Receives FDA Clearance of SP-3164..

Apertura: 0,4598	Min: 0,3868	Max: 0,4598
Chiusura: 0,4595